| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.5 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in Cisco IOS XR. This issue affects some unknown processing of the component CLI. Such manipulation leads to access control. This vulnerability is documented as CVE-2020-3473. The attack needs to be performed locally. There is not any exploit available. You should upgrade the affected component.
Details
A vulnerability was found in Cisco IOS XR (Router Operating System) (affected version not known) and classified as critical. Affected by this issue is some unknown functionality of the component CLI. The manipulation with an unknown input leads to a access control vulnerability. Using CWE to declare the problem leads to CWE-264. Impacted is confidentiality, integrity, and availability. CVE summarizes:
A vulnerability in task group assignment for a specific CLI command in Cisco IOS XR Software could allow an authenticated, local CLI shell user to elevate privileges and gain full administrative control of the device. The vulnerability is due to incorrect mapping of a command to task groups within the source code. An attacker could exploit this vulnerability by first authenticating to the local CLI shell on the device and using the CLI command to bypass the task group–based checks. A successful exploit could allow the attacker to elevate privileges and perform actions on the device without authorization checks.
The weakness was released 09/04/2020 as cisco-sa-iosxr-LJtNFjeN as confirmed advisory (Website). The advisory is shared for download at tools.cisco.com. This vulnerability is handled as CVE-2020-3473 since 12/12/2019. The attack needs to be approached locally. A simple authentication is required for exploitation. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 09/04/2020). The MITRE ATT&CK project declares the attack technique as T1068.
Upgrading eliminates this vulnerability.
Entry connected to this vulnerability is available at VDB-160740. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.8VulDB Meta Temp Score: 7.6
VulDB Base Score: 7.8
VulDB Temp Score: 7.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Access controlCWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: No
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
12/12/2019 🔍09/04/2020 🔍
09/04/2020 🔍
11/12/2020 🔍
Sources
Vendor: cisco.comAdvisory: cisco-sa-iosxr-LJtNFjeN
Status: Confirmed
CVE: CVE-2020-3473 (🔍)
GCVE (CVE): GCVE-0-2020-3473
GCVE (VulDB): GCVE-100-160736
scip Labs: https://www.scip.ch/en/?labs.20150108
See also: 🔍
Entry
Created: 09/04/2020 13:42Updated: 11/12/2020 18:16
Changes: 09/04/2020 13:42 (40), 09/04/2020 13:47 (12), 11/12/2020 18:16 (1)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.

No comments yet. Languages: en.
Please log in to comment.